An authorized generic of Cleocin Phosphate was sold before, but it isn’t sold now. Ask your pharmacist whether a regular generic (clindamycin phosphate) is available.
Source: FDA, updated October 30, 2026
Cleocin Phosphate is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.
How to pay the least
Given by your care team
Billed by the clinic
Cleocin Phosphate is given by a doctor or nurse, not picked up at a pharmacy.
- Ask your care team or your plan what you’d pay before your visit.
Compare every option
Question
Brand nameCleocin Phosphate
Authorized genericclindamycin
Regular genericclindamycin
What you’d pay
Cash priceAsk the pharmacyUsually the highest price
Not soldNo longer sold
Cash priceAsk the pharmacyUsually the lowest
Same as the brand?
The original
–
Same active ingredientFillers and dyes can differ
Details for each option
Details for
Brand nameNo maker’s card
We didn’t find a savings card or cash price from Cleocin Phosphate’s maker. Ask the pharmacy for Cleocin Phosphate’s cash price. With insurance, ask what your plan charges.
Authorized genericNot sold now
Regular genericWho makes it
One company sells an FDA-rated generic of Cleocin Phosphate. It’s given by your care team, who choose which one to use.
-
Sagent Pharmaceuticals150 mg/mL
Product page on sagentpharma.com
How it looks, what’s in it, NDCs
150 mg/mL
Package NDC Carton of 50 mL 25021-115-02 Carton of 100 mL 25021-115-04 Carton of 150 mL 25021-115-06 Inactive ingredients: edetate disodium, benzyl alcohol, sodium hydroxide, hydrochloric acid
Who sells it: FDA and Medicaid records, updated weekly. Each maker’s page, card and program is from its own site.
What it’s used for
- Skin infections
- Lung and airway infections
- Infections inside the belly
- Gynecologic infections
- Bone and joint infections
- Blood infections (septicemia)
What the FDA label says
CLEOCIN PHOSPHATE products are indicated in the treatment of serious infections caused by susceptible anaerobic bacteria.
CLEOCIN PHOSPHATE products are also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of antibacterial drug-associated pseudomembranous colitis, as described in the BOXED WARNING, before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (e.g., erythromycin).
Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin.
Indicated surgical procedures should be performed in conjunction with antibacterial drug therapy.
CLEOCIN PHOSPHATE is indicated in the treatment of serious infections caused by susceptible strains of the designated organisms in the conditions listed below:
Lower respiratory tract infections including pneumonia, empyema, and lung abscess caused by anaerobes, Streptococcus pneumoniae, other streptococci (except E. faecalis), and Staphylococcus aureus.
Skin and skin structure infections caused by Streptococcus pyogenes, Staphylococcus aureus, and anaerobes.
Gynecological infections including endometritis, nongonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infection caused by susceptible anaerobes.
Intra-abdominal infections including peritonitis and intra-abdominal abscess caused by susceptible anaerobic organisms.
Septicemia caused by Staphylococcus aureus, streptococci (except Enterococcus faecalis), and susceptible anaerobes.
Bone and joint infections including acute hematogenous osteomyelitis caused by Staphylococcus aureus and as adjunctive therapy in the surgical treatment of chronic bone and joint infections due to susceptible organisms.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of CLEOCIN PHOSPHATE and other antibacterial drugs, CLEOCIN PHOSPHATE should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Source: the FDA label for Cleocin Phosphate (Pharmacia & Upjohn Company LLC), July 29, 2026. Full label on DailyMed
Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/cleocin-phosphate/